Akoya Biosciences Inc (AKYA): רווח נקי למניה (EPS TTM)

Can the management of Akoya Biosciences (AKYA) ensure stable operating income? The low cyclicality of demand for spatial biology equipment and the support of R&D budgets make the business resilient. The rolling year earnings per share on GURU.Markets reflects current dynamics, where the metric level is -0.96. Long-term revenue is based on regular sales of proprietary reagents following a "razor-and-blade" model.
פילוחים אנליטיים ודוחות נתונים של חברת Akoya (AKYA)

Earnings per share (EPS TTM) measures the portion of profit allocated to each security over the last twelve months. This metric allows an investor to assess the actual efficiency of the business by stripping away the volatility of market quotes. By analyzing the TTM earnings per share trend, one can determine the quality of capital management. For Akoya Biosciences (AKYA), this indicator depends directly on the volume of biomedical grants and the pace of laboratory equipment upgrades.